Hypermethylation of HLA class i gene is associated with HLA class i down-regulation in human gastric cancer

Tissue Antigens

Volumn 75, Issue 1, 2010, Pages 30-39

  Ye, Q ^a   Shen, Y ^a   Wang, X ^a   Yang, J ^a   Miao, F ^a   Shen, C ^a   Zhang, J ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Gastric cancer; Human leukocyte antigen class I molecule; Methylation

Indexed keywords

DNA METHYLTRANSFERASE INHIBITOR; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; MESSENGER RNA;

ADULT; AGED; ALKYLATION; ARTICLE; CANCER TISSUE; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE LOCUS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERMETHYLATION; IMMUNOHISTOCHEMISTRY; MALE; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER;

CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DNA METHYLATION; DOWN-REGULATION; EPIGENESIS, GENETIC; GENES, MHC CLASS I; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; STOMACH NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 72649095844     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2009.01390.x     Document Type: Article

References (32)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005 : 55 : 74 108.
2. Jimenez P, Canton J, Concha A et al. Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression. Cancer Immunol Immunother 2000 : 48 : 684 690.
3. Nie Y, Yang G, Song Y et al. DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas. Carcinogenesis 2001 : 22 : 1615 1623.
4. Garrido F, Ruiz-Cabello F, Cabrera T. Implications for immunosurveillance of altered HLA class I phenotypes in human tumors. Immunol Today 1997 : 18 : 89 95.
5. Arapshian A, Bertran S, Kuppumbatti YS et al. Epigenetic CRBP down-regulation appears to be an evolutionarily conserved (human and mouse) and oncogene-specific phenomenon in breast cancer. Mol Cancer 2004 : 3 : 13 24.
6. Eckhardt F, Lewin J, Cortese R et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 2006 : 38 : 1359 1360.
7. INK4a promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions. Lung Cancer 2005 : 48 : 299 306.
8. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 2001 : 61 : 2847 2851.
9. Hicklin DJ, Marincola FM, Ferrone S. HLA class I antigen down-regulation in human cancers: T-cell immunotherapy revives an old story. Mol Med Today 1999 : 5 : 178 186.
10. Yuqing S, Jianqiong Zh, Jianming Zh et al. HLA class I antigen down-regulation in gastric cancer in the Jiangsu province, China. (abstract) Tissue Antigens 2002 : 59(s) : 118 119.
11. López-Nevot MA, Esteban F, Ferrón A et al. HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas. Br J Cancer 1989 : 59 : 221 226.
12. Wang XC, Zhang JQ, Shen YQ et al. Loss of heterozygosity at 6p21.3 underlying HLA class I down-regulation in gastric cancer. J Exp Clin Cancer Res 2006 : 25 : 115 119.
13. Sun X, Mu R, Zhou Y et al. 1990-1992 mortality of stomach cancer in China. Chin J Oncol 2002 : 24 : 101 105.
14. Shen YQ, Zhang JQ, Miao FQ et al. Relationship between the down-regulation of HLA class I antigen and clinicopathological significance in gastric cancer. World J Gastroenterol 2005 : 11 : 3628 3631.
15. Satoh A, Toyota M, Ikeda H et al. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma- induced HLA-DR expression in colorectal and gastric cancer cells. Oncogene 2004 : 23 : 8876 8886.
16. Hirata T, Yamamoto H, Taniguchi H et al. Characterization of the immune escape phenotype of human gastric cancers with and without high-frequency microsatellite instability. J Pathol 2007 : 211 : 516 523. (Pubitemid 46502427)
17. Wang X, Liang B, Rebmann V et al. Specificity and functional characteristics of anti-HLA A mAbs LGIII-147.4.1 and LGIII-220.6.2. Tissue Antigens 2003 : 62 : 139 148.
18. Owonikoko T, Loberg C, Gabbert HE, Sarbia M. Comparative analysis of basaloid and typical squamous cell carcinoma of the oesophagus: a molecular biological and immunohistochemical study. J Pathol 2001 : 193 : 155 161.
19. Sernee MF, Ploegh HL, Schust DJ. Why certain antibodies cross-react with HLA-A and HLA-G: epitope mapping of two common MHC class I reagents. Mol Immunol 1998 : 35 : 177 188.
20. Barnstable CJ, Bodmer WF, Brown G et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens - new tools for genetic analysis. Cell 1978 : 14 : 9 20.
21. Feenstra M, Veltkamp M, VanKuik J et al. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas. Tissue Antigens 1999 : 54 : 235 245.
22. Garrido F, Cabrera T, Accolla RS et al. HLA and Cancer: 12th International Histocompatibility Workshop study. In: Charron D., ed. Genetic Diversity of HLA. Functional and Medical Implication. Proceedings of the 12th International Histocompatibility Workshop and Conference. France : EDK Sevres, 1997, 445 452.
23. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Balin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996 : 93 : 9821 9826.
24. Vitale M, Rezzani R, Rodella L et al. HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions. Cancer Res 1998 : 58 : 737 742.
25. Matsui M, Ikeda M, Akatsuka T. High expression of HLA-A2 on an oral squamous cell carcinoma with down-regulated transporter for antigen presentation. Biochem Biophys Res Commun 2001 : 280 : 1008 1014.
26. Serrano A, Tanzarella S, Lionello I et al. Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2′-deoxycytidine treatment. Int J Cancer 2001 : 94 : 243 251. (Pubitemid 32911420)
27. Griffioen M, Ouwerkerk IJ, Harten V, Schrier PI. HLA-B down-regulation in human melanoma is mediated by sequences located downstream of the transcription-initiation site. Int J Cancer 1999 : 80 : 573 580.
28. Ueda Y, Ishikawa K, Shiraishi N, Yokoyama S, Kitano S. Clinical significance of HLA class I heavy chain expression in patients with gastric cancer. J Surg Oncol 2008 : 97 : 451 455.
29. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971 : 68 : 820 823.
30. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999 : 21 : 163 167.
31. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000 : 16 : 168 174.
32. Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol 2005 : 45 : 629 656.